ClinicalTrials.Veeva

Menu

Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSIL

U

University of Electronic Science and Technology of China (UESTC)

Status

Completed

Conditions

High-Grade Squamous Intraepithelial Lesions

Treatments

Procedure: surgical timing and operation path

Study type

Observational

Funder types

Other

Identifiers

NCT06325592
REHSIL2023V1.1

Details and patient eligibility

About

This study aimed to analyze perioperative information in patients with high-grade squamous intraepithelial lesion (HSIL) undergoing total hysterectomy (TH), offering insights into optimal surgery timing, selecting the operation path, and enhancing surgical operation details.

Enrollment

826 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients were confirmed with HSIL through pathology at our hospital or another tertiary facility, with additional confirmation via pathological consultation at our facility;
  • LH or abdominal hysterectomy (AH) +/- bilateral fallopian tube or bilateral adnexectomy was performed after LEEP;
  • the patient had no history of systemic malignancies.

Exclusion criteria

  • severe medical and surgical complications;
  • an extensive or subextensive hysterectomy was performed;
  • surgical removal scope involving tissues (such as lymph nodes) or organs (such as the appendix) other than the uterus, ovaries, and fallopian tubes;
  • fever symptoms within the last month;
  • incidence of pelvic and abdominal infections, vaginitis, or similar conditions within the past month.

Trial design

826 participants in 5 patient groups

group 1
Description:
patients underwent laparoscopic hysterectomy within 3 days after LEEP
Treatment:
Procedure: surgical timing and operation path
group 2
Description:
patients underwent abdominal hysterectomy within 3 days after LEEP
Treatment:
Procedure: surgical timing and operation path
group 3
Description:
patients underwent laparoscopic hysterectomy 4 weeks after LEEP
Treatment:
Procedure: surgical timing and operation path
group 4
Description:
underwent abdominal hysterectomy 4 weeks after LEEP
Treatment:
Procedure: surgical timing and operation path
control group
Description:
Patients who underwent laparoscopic hysterectomy (LH) due to benign gynecological diseases were included in the control group.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems